Ultrahuman and Click Therapeutics Join to Create Biomarker-Driven Migraine Tool

A new collaboration between two tech-driven health companies aims to harness biomarkers and AI to improve migraine treatment.

Ultrahuman and Click Therapeutics announced a partnership to develop a biomarker-driven digital therapeutic tool for migraine management. The collaboration integrates Click’s AI-based migraine treatment platform with Ultrahuman’s wearable and biomarker analytics technology.

Ultrahuman CEO said:

"This partnership aims to redefine personalized care by combining real-time biomarker data with AI-driven behavioral interventions."

Click Therapeutics CEO said:

"Our goal is to address migraine triggers proactively using precise, data-informed strategies."

⚠️ LEGAL DISCLAIMER: It is for informational purposes only. It never substitutes for professional medical advice, diagnosis, or treatment. Always consult your doctor regarding any questions about your health.